My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 141

    1.

    Activated protein C resistance in patients with central retinal vein occlusion.

    Larsson J, Sellman A, Bauer B.

    Br J Ophthalmol. 1997 Oct;81(10):832-4.PMID: 9486021 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Activated protein C resistance in young adults with central retinal vein occlusion.

    Larsson J, Olafsdottir E, Bauer B.

    Br J Ophthalmol. 1996 Mar;80(3):200-2.PMID: 8703855 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [Retinal vein occlusion and resistance to activated protein C]

    Scat Y, Morin Y, Morel C, Haut J.

    J Fr Ophtalmol. 1995;18(12):758-62. French. PMID: 8745708 [PubMed - indexed for MEDLINE]Related articles

    4.

    Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion.

    Larsson J, Hillarp A, Olafsdottir E, Bauer B.

    Acta Ophthalmol Scand. 1999 Dec;77(6):634-7.PMID: 10634554 [PubMed - indexed for MEDLINE]Related articles

    5.

    Retinal vascular occlusion and deficiencies in the protein C pathway.

    Greiner K, Hafner G, Dick B, Peetz D, Prellwitz W, Pfeiffer N.

    Am J Ophthalmol. 1999 Jul;128(1):69-74.PMID: 10482096 [PubMed - indexed for MEDLINE]Related articles

    6.

    Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults.

    Gottlieb JL, Blice JP, Mestichelli B, Konkle BA, Benson WE.

    Arch Ophthalmol. 1998 May;116(5):577-9.PMID: 9596492 [PubMed - indexed for MEDLINE]Related articles

    7.

    Activated protein C resistance is a risk factor for central retinal vein occlusion.

    Marcucci R, Bertini L, Liotta AA, Rogolino A, Antonucci E, Ilari I, Pepe G, Prisco D.

    Ann Ital Med Int. 2000 Jul-Sep;15(3):195-8.PMID: 11059059 [PubMed - indexed for MEDLINE]Related articles

    8.

    Genetic thrombophilia in patients with retinal vascular occlusion.

    Greiner K, Peetz D, Winkgen A, Prellwitz W, Pfeiffer N, Hafner G.

    Int Ophthalmol. 1999;23(3):155-60.PMID: 11456253 [PubMed - indexed for MEDLINE]Related articles

    9.

    Factor V Leiden, activated protein C resistance, and retinal vein occlusion.

    Ciardella AP, Yannuzzi LA, Freund KB, DiMichele D, Nejat M, De Rosa JT, Daly JR, Sisco L.

    Retina. 1998;18(4):308-15.PMID: 9730172 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Thrombophilia factors as inducers of retinal vascular occlusion]

    Lerche RC, Wilhelm C, Eifrig B, Richard G.

    Ophthalmologe. 2001 Jun;98(6):529-34. German. PMID: 11450475 [PubMed - indexed for MEDLINE]Related articles

    11.

    Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age.

    Lahey JM, Tunç M, Kearney J, Modlinski B, Koo H, Johnson RN, Tanaka S.

    Ophthalmology. 2002 Jan;109(1):126-31.PMID: 11772591 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Activated protein C resistance in patients with central retinal vein occlusion in comparison to patients with a history of deep-vein thrombosis and a healthy control group]

    Faude S, Faude F, Siegemund A, Wiedemann P.

    Ophthalmologe. 1999 Sep;96(9):594-9. German. PMID: 10501988 [PubMed - indexed for MEDLINE]Related articles

    13.

    Activated protein C resistance--low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion.

    Graham SL, Goldberg I, Murray B, Beaumont P, Chong BH.

    Aust N Z J Ophthalmol. 1996 Aug;24(3):199-205.PMID: 8913121 [PubMed - indexed for MEDLINE]Related articles

    14.

    Central retinal vein thrombosis associated with resistance to activated protein C.

    Dhôte R, Bachmeyer C, Horellou MH, Toulon P, Christoforov B.

    Am J Ophthalmol. 1995 Sep;120(3):388-9.PMID: 7661212 [PubMed - indexed for MEDLINE]Related articles

    15.

    Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.

    Williamson TH, Rumley A, Lowe GD.

    Br J Ophthalmol. 1996 Mar;80(3):203-8.PMID: 8703856 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance.

    Greven CM, Wall AB.

    Am J Ophthalmol. 1997 Nov;124(5):687-9.PMID: 9372725 [PubMed - indexed for MEDLINE]Related articles

    17.

    Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion.

    Tekeli O, Gürsel E, Buyurgan H.

    Acta Ophthalmol Scand. 1999 Dec;77(6):628-30.PMID: 10634552 [PubMed - indexed for MEDLINE]Related articles

    18.

    High prevalence of resistance to APC in young patients with retinal vein occlusion.

    Kuhli C, Hattenbach LO, Scharrer I, Koch F, Ohrloff C.

    Graefes Arch Clin Exp Ophthalmol. 2002 Mar;240(3):163-8. Epub 2002 Feb 22.PMID: 11935272 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hypercoagulable states in patients with retinal venous occlusion.

    Abu El-Asrar AM, Abdel Gader AG, Al-Amro S, Al-Momen AK.

    Doc Ophthalmol. 1998;95(2):133-43.PMID: 10431797 [PubMed - indexed for MEDLINE]Related articles

    20.

    Protein Z levels and central retinal vein or artery occlusion.

    Koren-Michowitz M, Eting E, Rahimi-Levene N, Garach-Jehoshua O, Volcheck Y, Kornberg A.

    Eur J Haematol. 2005 Nov;75(5):401-5.PMID: 16191090 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity